dabigatran has been researched along with Obesity, Morbid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdulsattar, W; Al-Abdouh, A; Alom, M; Assaly, R; Ayesh, H; Beran, A; Hamouda, D; Khuder, SA; Mhanna, M; Sajdeya, O; Srour, O | 1 |
| An, J; Duan, L; Huang, CW; Lee, MS; Sim, JJ | 1 |
| Albert, L; Bejjani, A; Coons, JC; Iasella, CJ | 1 |
| Nasir, U | 1 |
| Kido, K; Ngorsuraches, S | 1 |
| Abrahám, P; Andréka, P; Csillik, A; Földesi, C; Fontos, G; Kardos, A; Kis, Z; Pál, M; Som, Z; Szatmári, A; Temesvári, A | 1 |
1 review(s) available for dabigatran and Obesity, Morbid
| Article | Year |
|---|---|
Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-analysis.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Obesity, Morbid; Retrospective Studies; Rivaroxaban; Stroke; Warfarin | 2021 |
5 other study(ies) available for dabigatran and Obesity, Morbid
| Article | Year |
|---|---|
Effectiveness and Safety of Dabigatran in Atrial Fibrillation Patients with Severe Obesity: a Real-World Retrospective Cohort Study.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Gastrointestinal Hemorrhage; Humans; Obesity, Morbid; Retrospective Studies; Stroke; Thromboembolism; Treatment Outcome; Warfarin | 2022 |
Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism.
Topics: Administration, Oral; Aged; Anticoagulants; Cohort Studies; Dabigatran; Female; Humans; Male; Middle Aged; Obesity, Morbid; Pulmonary Embolism; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Treatment Outcome; Venous Thromboembolism; Warfarin | 2020 |
Pulmonary embolism in a morbidly obese patient receiving dabigatran.
Topics: Antithrombins; Blood Coagulation; Body Mass Index; Dabigatran; Drug Substitution; Humans; Male; Middle Aged; Obesity, Morbid; Pulmonary Embolism; Risk Factors; Rivaroxaban; Treatment Failure | 2017 |
Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Obesity, Morbid; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Warfarin; Young Adult | 2019 |
[Percutaneous left atrial appendage closure after resolution of left atrial appendage thrombi with dabigatran].
Topics: Anticoagulants; Antithrombins; Atherectomy; Atrial Appendage; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Comorbidity; Dabigatran; Echocardiography, Transesophageal; Female; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Obesity, Morbid; Risk Factors; Stroke; Thrombosis; Treatment Outcome | 2013 |